Intrahepatic CD69(+)Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression

BACKGROUND: More than 50% of all patients with colorectal cancer (CRC) develop liver metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable prognostic markers. Vδ1 cells are a subset of tissue-resident gamma delta (γδ) T lymphocytes endowed with a broad array of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruni, Elena, Cimino, Matteo Maria, Donadon, Matteo, Carriero, Roberta, Terzoli, Sara, Piazza, Rocco, Ravens, Sarina, Prinz, Immo, Cazzetta, Valentina, Marzano, Paolo, Kunderfranco, Paolo, Peano, Clelia, Soldani, Cristiana, Franceschini, Barbara, Colombo, Federico Simone, Garlanda, Cecilia, Mantovani, Alberto, Torzilli, Guido, Mikulak, Joanna, Mavilio, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310256/
https://www.ncbi.nlm.nih.gov/pubmed/35863820
http://dx.doi.org/10.1136/jitc-2022-004579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310256/
https://www.ncbi.nlm.nih.gov/pubmed/35863820
http://dx.doi.org/10.1136/jitc-2022-004579

Ejemplares similares